RXM THERAPEUTICS

Serial Number 86749911
Registration 5498187
710

Registration Progress

Application Filed
Sep 8, 2015
Under Examination
May 3, 2016
Approved for Publication
Mar 8, 2016
Published for Opposition
Mar 8, 2016
Registered
Jun 19, 2018

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: RXM THERAPEUTICS
Previous Owner: AZURITY PHARMACEUTICALS, INC.

Trademark Image

RXM THERAPEUTICS

Basic Information

Serial Number
86749911
Registration Number
5498187
Filing Date
September 8, 2015
Registration Date
June 19, 2018
Published for Opposition
March 8, 2016
Cancellation Date
January 3, 2025
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
710
Status Date
Jan 3, 2025

Rights Holder

AZURITY PHARMACEUTICALS, INC.

03
Address
8 CABOT ROAD, SUITE 2000
WOBURN, MA 01801

Ownership History

CutisPharma, Inc.

Original Applicant
03
Wilmington, MA

CutisPharma, Inc.

Owner at Publication
03
Wilmington, MA

CutisPharma, Inc.

Original Registrant
03
Woburn, MA

AZURITY PHARMACEUTICALS, INC.

New Owner After Registration #1
03
WOBURN, MA

Legal Representation

Attorney
Douglas R. Wolf

USPTO Deadlines

Next Deadline
912 days remaining
Section 8 & 9 Renewal Due (Principal Register) (Based on R.PRA event 2018-06-19)
Due Date
June 19, 2028
Grace Period Ends
December 19, 2028

Application History

38 events
Date Code Type Description Documents
Jan 3, 2025 C8.. O CANCELLED SEC. 8 (6-YR) Loading...
Jun 19, 2023 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Apr 29, 2020 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
May 23, 2019 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
May 23, 2019 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Mar 26, 2019 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Mar 26, 2019 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jun 19, 2018 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
May 16, 2018 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
May 15, 2018 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Apr 4, 2018 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Mar 27, 2018 IUAF S USE AMENDMENT FILED Loading...
Mar 27, 2018 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Sep 27, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 25, 2017 EX3G S SOU EXTENSION 3 GRANTED Loading...
Sep 25, 2017 EXT3 S SOU EXTENSION 3 FILED Loading...
Sep 25, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 22, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 21, 2017 EX2G S SOU EXTENSION 2 GRANTED Loading...
Mar 13, 2017 EXT2 S SOU EXTENSION 2 FILED Loading...
Mar 19, 2017 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Mar 13, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 24, 2016 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 22, 2016 EX1G S SOU EXTENSION 1 GRANTED Loading...
Sep 22, 2016 EXT1 S SOU EXTENSION 1 FILED Loading...
Sep 22, 2016 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 3, 2016 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 8, 2016 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 8, 2016 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 17, 2016 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 21, 2015 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 21, 2015 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Dec 21, 2015 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Dec 21, 2015 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Dec 21, 2015 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Dec 19, 2015 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 11, 2015 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 11, 2015 NWAP I NEW APPLICATION ENTERED Loading...

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"